Incannex Receives Ethics Approval for Bioequivalence/Bioavailability Clinical Trial for IHL-42X, the Company’s Proprietary Drug for Treatment of Obstructive Sleep Apnoea (‘OSA’)
06 juil. 2023 08h42 HE
|
Incannex Healthcare
Highlights: Incannex has received approval from Bellberry Human Research Ethics Committee (‘HREC’) to commence the bioavailability/bioequivalence (‘BA/BE’) clinical trial to assess the...
Cortexa Makes First Drug Order for Australian Commercial Market
04 juil. 2023 08h55 HE
|
PharmAla Biotech
VANCOUVER, British Columbia, July 04, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:PMBHF), a biotechnology company focused on the research,...
Momentum Events Celebrates Historic Conference, Psychedelic Science 2023
23 juin 2023 14h47 HE
|
Psychedelic Science 2023
DENVER, June 23, 2023 (GLOBE NEWSWIRE) -- Momentum Events, one of the nation’s leading event production companies with a specialization in producing conferences and trade shows focused on emerging...
MAPS Receives $5 Million Grant from the Steven & Alexandra Cohen Foundation
22 juin 2023 08h00 HE
|
Multidisciplinary Association for Psychedelic Studies (MAPS)
SAN JOSE, Calif., June 22, 2023 (GLOBE NEWSWIRE) -- The Multidisciplinary Association for Psychedelic Studies (MAPS) today announced that the Steven & Alexandra Cohen Foundation has awarded MAPS...
PharmAla Biotech Receives Export Permit to Ship GMP LaNeo MDMA to the University of Sydney
16 juin 2023 09h00 HE
|
PharmAla Biotech
VANCOUVER, British Columbia, June 16, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:PMBHF, a biotechnology company focused on the research,...
Optimi Health To Supply MDMA For Therapist Experiential Training Program at Numinus, Supported by MAPS
15 juin 2023 09h40 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, June 15, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), an end-to-end drug researcher and formulator...
PharmAla Awarded Research Grant by Ontario Centre for Innovation
09 juin 2023 13h18 HE
|
PharmAla Biotech
TORONTO, June 09, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA)(OTC:PMBHF), a biotechnology company focused on the research, development, and manufacturing of novel...
Clearmind Medicine to Host Virtual Investor Conference on Psychedelics for Obesity
09 juin 2023 09h30 HE
|
Clearmind Medicine Inc.
The conference will stream live on Monday, June 12, at 10:00 AM EST Tel Aviv, Israel / Vancouver, Canada, June 09, 2023 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND), (FSE:...
Colorado Governor Jared Polis Named Opening Speaker for Psychedelic Science 2023
09 juin 2023 08h00 HE
|
Psychedelic Science 2023
DENVER, June 09, 2023 (GLOBE NEWSWIRE) -- Psychedelic Science 2023, the breakthrough psychedelic conference hosted by Multidisciplinary Association for Psychedelic Studies (MAPS) and organized by...
atai Life Sciences nimmt an kommenden Investorenkonferenzen im Juni teil
05 juin 2023 05h49 HE
|
atai Life Sciences
NEW YORK und BERLIN, June 05, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) („atai“), ein im klinischen Stadium tätiges Biopharmazieunternehmen, das die Behandlung von psychischen...